Table 2. Biochemical analysis after 14 weeks of solutions consumption.
| Characteristics | HS | SS | GFS |
|---|---|---|---|
| Glucose (mg/dL) | 110.7 ± 23.16NS | 119.75 ± 26.62 | 118.7 ± 26.04 |
| Insulin (μIU/mL) | 4.32 ± 4.07 | 4.87 ± 0.38 | 4.74 ± 0.47 |
| HOMA2-IR | 0.58 ± 0.54 | 0.67 ± 0.05 | 0.65 ± 0.05 |
| HOMA2-%B | 44.88 ± 26.95 | 43.68 ± 14.53 | 44.07 ± 15.69 |
| Leptin (pg/mL) | 555 ± 599 | 721 ± 507 | 549 ± 395 |
| TC (mg/100 mL) | 54.5 ± 7.33 | 48.87 ± 2.41 | 52.3 ± 8.61 |
| HDL-C (mg/100 mL) | 39.10 ± 9.44 | 36.25 ± 7.59 | 36.2 ± 5.99 |
| VLDL (mg/100 mL) | 20.44 ± 13.75 | 16.47 ± 6.55 | 22.92 ± 11.23 |
| Triglycerides (mg/100 mL) | 102.2 ± 68.79 | 82.37 ± 32.77 | 114.6 ± 56.19 |
| Atherogenic risk index (%) | 0.31 ± 0.47 | 0.31 ± 0.22 | 0.32 ± 0.15 |
HS, honey solution; SS, sucrose solution; GFS, glucose/fructose solution; HOMA2-IR, homeostatic model assessment for insulin resistance; HOMA2-%B, homeostatic model assessment β-cell function percent; TC, total cholesterol; HDL-C, high density lipoprotein-cholesterol; VLDL, very low density lipoprotein; NS, according to Tukey's test, no statistical significance was found among the groups in any variable.